Kindly advice on below my portfolio, I have shortlisted 20 stocks for long term investment (ready to hold more than 10+ years) . is it ok have 20 stocks in portfolio or should I reduce to 15. advice on my stock selection as well
ACC
PIDILITIND
BATA INDIA
TITAN
NATCO PHARM
JB CHEM @ PHARM
CIPLA
CASTROL
BHEL
COAL INDIA
HDFC BANK
SBI
HUL
ITC
MOTHERSUMI
ESCORTS
ONGC
INFOSYS
WIPRO
TITAN
Bulk Deals
As on 08 Dec 15
Listed below are the Bulk Deals reported by the Members.
All Prices in ![[IMG]](http://www.bseindia.com/include/images/rs_b.gif)
Deal Date Security Code Security Name Client Name Deal Type * Quantity Price **
08/12/2015 531223 ANJANI DEEPINDER SINGH POONIAN B 80,389 18.28
08/12/2015 531223 ANJANI NISHA KANUBHAI MAKWANA S 86,000 18.58
08/12/2015 530723 ASITCFIN CHARU SHIRISH SHAH B 55,000 40.3
08/12/2015 530723…
GST Bill is unlikely to get cleared in the current session of Parliament as the parties have reverted back to fighting mode. After today's hungama in Rajyasabha, it is unlikely that BJP and Congress will sit together on one table and discuss GST.
Dr Lal PathLabs is one of the largest companies in the Indian diagnostic industry, having a market share of 12.0% amongst diagnostic chains. It’s one of the fastest growing companies in the space with strong profitability. Dominant player in the industry: The company, according to our estimates, is the second largest player with an estimated ~12% market share in the organised diagnostic chains. It has grown at a CAGR of 20.7% over FY2013-15, primarily driven by volumes which grew 16.7%…
Alkem Laboratories (Alkem) is among the largest companies in the Indian formulation market, having a market share of 3.6%. The company is the fifth largest pharmaceutical company in India by domestic sales. Currently, domestic markets constitute around 75% of its sales; while in terms of exports, the company is at a relatively nascent stage vis-a-vis its peers. In exports (predominately US), the company is expanding through both the inorganic and the organic route. Alkem has 16 manufacturing…
The Goods and Services Tax (GST) has the potential to transform businesses and bring in enormous efficiencies – tax and operational. The focus today, unfortunately, is too much on the rate harmonization. Rather, the focus should be on tax administration harmonization. EU GST is an example, where different nation states have different rates, while having similar tax admin structure leading to lower compliance costs.
The Chief Economic Advisor (CEA) panel has recommended a Revenue Neutral…
Dear All,
I have been reading your blog for last few months and have been highly impressed with your knowledge and selfless services.
In the same regards i wanted your advise.
I hold the below listed scrips in my name and want your advice that which ones should i liquidate and which ones i should keep for medium to long term.
1 Allied Digital Technology 4350
2 Anant Raj Real Estate 5000
3 Bartonics Technology 500
4 Bharat Forge Ltd. Auto Ancilliary 100
5 BSEL Infra Realty Real Estate…
PORINJUV VELIYATH entered in to TERASOFT
Dr. Lal PathLabs: Subscribe
Issue opens 08-Dec-15, Issue closes 10-Dec-15, Price band Rs540-550
Dr Lal PathLabs (DLP) runs diagnostic laboratories chain of 172 pathology labs and 1,554 patience service centers across India. North India accounted for 73% of H1 FY16 revenues and DLP has posted robust revenue and PAT cagr of 21% and 30% respectively over FY13-15 and we expect the momentum to continue with ~19% and 21% cagr respectively over FY15-18E. At the upper price band of…
Alkem Laboratories: Subscribe
Issue opens 08-Dec-15, Issue closes 10-Dec-15, Price band Rs1,020-1,050
Alkem Laboratories owns a bouquet of leadership brands built and sustained over a long time and has emerged as the fifth largest domestic pharma company. Promoted by Mr. Samprada Singh and Mr. Basudeo Singh, company is tied at 2nd spot with five brands in top 50. Alkem has cemented its presence in intensely competitive and largest therapeutic segment anti infective on back of…